Last reviewed · How we verify

NCT04867213: BREATH

Breath Analysis of Patients Diagnosed With COVID-19 Using Infrared Spectroscopy

Status unknown Last updated 30 April 2021
What this trial tests

trial in SARS-CoV-2 Infection in 200 participants. Status unknown.

Timeline
15 February 2021
Primary endpoint
31 December 2021
31 March 2022

Quick facts

Lead sponsorMcMaster University
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment200
Start date15 February 2021
Primary completion31 December 2021
Estimated completion31 March 2022
Sites1 location across Canada

Conditions studied

Sponsor

McMaster University

Who can join

18 and older, any sex, with SARS-CoV-2 Infection or Covid19. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To analyze Volatile Organic Compounds (VOCs) in the breath of patients with SARS-CoV-2 and controls in SARS-CoV-2 breath specimens.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for SARS-CoV-2 Infection

Currently open trials in the same condition.

Other McMaster University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04867213.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing